Suppression of Collagen-Induced Arthritis by Oral Administration of the Citrus Flavonoid Hesperidin

Abstract

The preventive and therapeutic effects of the Citrus flavonoid hesperidin (HES) on the development of collagen-induced arthritis (CIA), a mouse model of rheumatoid arthritis (RA), were investigated. Mice were administered orally HES three times a week starting from either the onset (day 21) of secondary immunization or on day 31, when the CIA development had reached a plateau. In both cases, treatment with HES resulted in a significant suppression of clinical scores and improvement of histological features. These results suggest that oral administration of HES could be effective for treating human RA patients.

References

• 1 Feldmann M, Brennan F M, Chantry D, Haworth C, Turner M, Katsikis P. et al . Cytokine assays: role in evaluation of the pathogenesis of autoimmunity.  Immunol Rev. 1991;  119 105-23
• 2 Elson C J, Thompson S J, Westacott C I, Bhoola K D. Mediators of joint swelling and damage in rheumatoid arthritis and pristane induced arthritis.  Autoimmunity. 1992;  13 327-31
• 3 Klareskog L, McDevitt H. Rheumatoid arthritis and its animal models: the role of TNF-α and the possible absence of specific immune reactions.  Curr Opin Immunol. 1999;  11 657-62
• 4 Chu C Q, Field M, Feldmann M, Maini R N. Localization of tumor necrosis factor α in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis.  Arthritis Rheum. 1991;  34 1125-32
• 5 Brahn E, Peacock D J, Banquerigo M L, Liu D Y. Effects of tumor necrosis factor α (TNF-α) on collagen arthritis.  Lymphokine Cytokine Res. 1992;  11 253-6
• 6 Mikuls T R, Weaver A L. Lessons learned in the use of tumor necrosis factor-α inhibitors in the treatment of rheumatoid arthritis.  Curr Rheumatol Rep. 2003;  5 270-7
• 7 Taylor P C. Anti-TNFα therapy for rheumatoid arthritis: an update.  Intern Med. 2003;  42 15-20
• 8 Shanahan J C, St Clair W. Tumor necrosis factor-α blockade: a novel therapy for rheumatic disease.  Clin Immunol. 2002;  103 231-42
• 9 Graninger W B, Smolen J S. One-year inhibition of tumor necrosis factor-α: a major success or a larger puzzle.  Curr Opin Rheumatol. 2001;  13 209-13
• 10 Feldmann M, Maini R N. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?.  Annu Rev Immunol. 2001;  19 163-96
• 11 Kawaguchi K, Kikuchi S, Hasegawa H, Maruyama H , Morita H, Kumazawa Y. Suppression of lipopolysaccharide-induced tumor necrosis factor-release and liver injury in mice by naringin.  Eur J Pharmacol. 1999;  368 245-50
• 12 Kawaguchi K, Kikuchi S , Hasunuma R, Maruyama H , Yoshikawa T, Kumazawa Y. A citrus flavonoid hesperidin suppresses infection-induced endotoxin shock in mice.  Biol Pharm Bull. 2004;  27 679-83